Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Worst management ever
Let's get royalties from amazon
Someone tell oiddi to partner with amazon
Good to see them jump on a new cfo quickly. Also a good one
If you have Schwab it should be fixed soon so you can continue to buy :)
Anyone else not able to trade their existing shares?
Unbelievable
Will this bleeding ever stop?
Will this bleeding ever stop?
This is insane
Brutal over here as well
Well this is brutal
someone wants your shares. 45k on level 2 at 1.41
Dang we need a partner and yes a new CEO and frankly a new cfo. We need better industry connections and better communication outward
so i am sure when the calendar year flips over and everyone takes the tax loss many will be back for the fun next year. I am hoping all the mistakes that were made for Rexista will mean that Rega has minimal issues which is more important because it has twice the potential of rexista
According to Symphony Health Solutions, U.S. sales for the 12 months ended January 2017 for Lyrica® (pregabalin capsules) were approximately $4.2 billion (TRx MBS Dollars).
This is the big one
In March 2015, the FDA accepted a Pre-investigational new Drug (“Pre-IND”) meeting request for our once-a-day Regabatin™ XR non-generic controlled release version of pregabalin under the NDA 505(b)(2) regulatory pathway, with a view to possible commercialization in the U.S. at some time following the December 30, 2018 expiry of the patent covering the pregabalin molecule. Regabatin™ XR is based on our controlled release drug delivery technology platform which utilizes the symptomatology and chronobiology of fibromyalgia in a formulation intended to provide a higher exposure of pregabalin during the first 12 hours of dosing. Based on positive feedback and guidance from the FDA, we submitted an IND application for RegabatinTM XR in August 2015. The FDA completed its review of the IND application and provided constructive input that we will use towards further development of the program.
I think this could be a blessing in disguise.... by 2019 we could have 1) Regatabin, Rexista and all our generics approved with over a billion in sales. Not to mention there will be new products in the pipeline using the technology. Would rather have the partnership but even if we dilute and are up to 60,70,80 heck even 100 in outstanding shares we could still see + 10 bagger
Nice thanks!
When was Gluco approved?
http://www.intellipharmaceutics.com/pipeline.cfm
What I don't understand is why we haven't partnered our latest ANDA. It's supposed to have the biggest market of them all. Disappointing esp considering how quickly we partnered with Mac after approval.
All I am saying is that imo small dilution is coming before any partnership announcement. Hope you are right though as I am long and I agree with you that when July comes around all should be a lot better
It's not the cash. It's the dilution. You have to raise money at some point soon. Either through partnership or dilution. If I am big pharma I see that and I get greedier bc ipci soon will have no choice but to dilute if they don't decide on partnership. The dilution won't be much imo given the history but it will have if they can't decide on a partnership.
When you have no cash it's harder to negotiate a more favorable partnership for your self
Partnership
I think that language means they are working on something that will drive pps way up by feb in order to dilute. If not why would you state such strong language? Why not just leave the language we will run out of cash by May and be vague on when you will raise additional cash. They called out Feb for a reason IMO
By that I mean I sold way too soon. Just wanted to clarify
I was in bdsi at .87 and sold at 2.50. Not making the same mistake again
Well at least we can all take tax write offs now
Haha oh. Well no new additional dd here. Can't do anything but sit and wait. See what happens
I think she is pretty reputable and it's not looking good unfortunately. Although I don't know why it's taking so long to get revoked
so something really weird just happened....this morning when I checked the stock in my brokerage had a cuisp number only and the description said that registration was revoked. now I have the KADR symbol again and the registration revoked description just went away.
registration revoked
I agree. I think KADR is forever gone but I think we will become a cuisp number and a reverse merger can still take place "restructuring" the company in the future . How the rest of it unfolds I don't know. I think the unsecured debt can be gone either by swapping debt for equity or other ways. They can get creative with this. I still think this shell owns non operating revenue that is very valuable here. This is all my opinion of I agree with all your points.
KADR may not exist but the private company could use the KADR shell to go public once again right? The unsecured debt that is still in the shell could be converted to equity in the new company. Insiders and shareholders could get shares in the new company. The reorg would also allow the new company to use the net operating losses for tax savings purposes.
What if the CEO of the private company still owned a lot of shares of the KADR shell? And bc of hippo laws in the medical industry the contracts for a non operating business were valid and therefore the private company wanted them? Does that make sense? Thank you for your posts. I appreciate it.